Jane Street’s Aurinia Pharmaceuticals AUPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.27M | Sell |
85,600
-324,300
| -79% | -$4.74M | ﹤0.01% | 5997 |
|
|
2025
Q4 | $6.54M | Buy |
409,900
+16,900
| +4% | +$240K | ﹤0.01% | 2851 |
|
|
2025
Q3 | $4.34M | Buy |
393,000
+87,800
| +29% | +$959K | ﹤0.01% | 3634 |
|
|
2025
Q2 | $2.59M | Buy |
305,200
+13,100
| +4% | +$105K | ﹤0.01% | 4004 |
|
|
2025
Q1 | $2.35M | Sell |
292,100
-86,300
| -23% | -$699K | ﹤0.01% | 4094 |
|
|
2024
Q4 | $3.4M | Buy |
378,400
+149,600
| +65% | +$1.22M | ﹤0.01% | 3237 |
|
|
2024
Q3 | $1.68M | Sell |
228,800
-418,100
| -65% | -$2.59M | ﹤0.01% | 4844 |
|
|
2024
Q2 | $3.69M | Buy |
646,900
+425,800
| +193% | +$2.24M | ﹤0.01% | 3448 |
|
|
2024
Q1 | $1.11M | Buy |
221,100
+139,600
| +171% | +$947K | ﹤0.01% | 5225 |
|
|
2023
Q4 | $733K | Sell |
81,500
-70,100
| -46% | -$577K | ﹤0.01% | 6129 |
|
|
2023
Q3 | $1.18M | Buy |
151,600
+61,100
| +68% | +$598K | ﹤0.01% | 4944 |
|
|
2023
Q2 | $876K | Sell |
90,500
-180,100
| -67% | -$1.87M | ﹤0.01% | 5425 |
|
|
2023
Q1 | $2.97M | Buy |
270,600
+94,500
| +54% | +$833K | ﹤0.01% | 3159 |
|
|
2022
Q4 | $761K | Sell |
176,100
-116,800
| -40% | -$678K | ﹤0.01% | 5439 |
|
|
2022
Q3 | $2.2M | Sell |
292,900
-375,900
| -56% | -$3.25M | ﹤0.01% | 4044 |
|
|
2022
Q2 | $6.72M | Sell |
668,800
-506,600
| -43% | -$5.66M | ﹤0.01% | 2239 |
|
|
2022
Q1 | $14.6M | Sell |
1,175,400
-533,300
| -31% | -$8.24M | ﹤0.01% | 1562 |
|
|
2021
Q4 | $39.1M | Sell |
1,708,700
-30,500
| -2% | -$723K | 0.01% | 777 |
|
|
2021
Q3 | $38.5M | Buy |
1,739,200
+1,411,600
| +431% | +$22.4M | 0.01% | 716 |
|
|
2021
Q2 | $4.25M | Buy |
327,600
+185,200
| +130% | +$2.36M | ﹤0.01% | 2941 |
|
|
2021
Q1 | $1.85M | Sell |
142,400
-41,000
| -22% | -$595K | ﹤0.01% | 4166 |
|
|
2020
Q4 | $2.54M | Buy |
183,400
+136,000
| +287% | +$1.98M | ﹤0.01% | 3104 |
|
|
2020
Q3 | $698K | Buy |
47,400
+2,500
| +6% | +$36.2K | ﹤0.01% | 4656 |
|
|
2020
Q2 | $730K | Buy |
44,900
+3,700
| +9% | +$59.2K | ﹤0.01% | 4525 |
|
|
2020
Q1 | $598K | Buy |
41,200
+12,400
| +43% | +$219K | ﹤0.01% | 3431 |
|
|
2019
Q4 | $583K | Buy |
+28,800
| New | +$265K | ﹤0.01% | 3503 |
|
Other funds holding AUPH
TCM
NMC
